(NASDAQ: ATRC) Atricure's forecast annual revenue growth rate of 12.04% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.34%.
Atricure's revenue in 2026 is $552,157,000.On average, 11 Wall Street analysts forecast ATRC's revenue for 2026 to be $31,250,036,177, with the lowest ATRC revenue forecast at $29,895,896,640, and the highest ATRC revenue forecast at $32,435,541,285. On average, 11 Wall Street analysts forecast ATRC's revenue for 2027 to be $35,045,576,879, with the lowest ATRC revenue forecast at $33,360,245,397, and the highest ATRC revenue forecast at $36,349,075,447.
In 2028, ATRC is forecast to generate $39,459,443,824 in revenue, with the lowest revenue forecast at $37,414,561,455 and the highest revenue forecast at $40,953,858,849.